iShares Genomics Immunology and Healthcare ETF (IDNA) Research
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
Market snapshot
- Symbol
- IDNA
- Price
- $30.56
- Day change
- +0.56%
- Market cap
- $164.7M
- 52-week range
- 20.15-31.41
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- First Trust Dorsey Wright DALI Equity ETF (DALI)
- WisdomTree Global High Dividend Fund (DEW)
- Pacer Emerging Markets Cash Cows 100 ETF (ECOW)
- iShares ESG Advanced MSCI EM ETF (EMXF)
- iShares MSCI Austria ETF (EWO)
- Franklin FTSE Europe ETF (FLEE)
- Alpha Architect International Quantitative Momentum ETF (IMOM)
- John Hancock Investments - Preferred Income ETF (JHPI)
Open iShares Genomics Immunology and Healthcare ETF (IDNA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.